Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 16:11:1298956.
doi: 10.3389/fcell.2023.1298956. eCollection 2023.

Editorial: Methods and advances in induced pluripotent stem cells-ophthalmology

Lyle Armstrong  1 , Majlinda Lako  1
Affiliations
Editorial

Editorial: Methods and advances in induced pluripotent stem cells-ophthalmology

Lyle Armstrong et al. Front Cell Dev Biol. .
No abstract available

Keywords: eye development; photoreceptors; retina; retinal ganglion cells; retinal organoids.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Methods and advances in induced pluripotent stem cells—ophthalmology

References

    1. American Academy of Ophthalmology (1996). Preferred practice pattern of primary open angle glaucoma. San Francisco: American Academy of Ophthalmology.
    1. Chavali V. R. M., Haider N., Rathi S., Vrathasha V., Alapati T., He J., et al. (2020). Dual SMAD inhibition and Wnt inhibition enable efficient and reproducible differentiations of induced pluripotent stem cells into retinal ganglion cells. Sci. Rep. 10, 11828. 10.1038/s41598-020-68811-8 - DOI - PMC - PubMed
    1. Chen Y., Zhou Y., Zhou Z., Fang Y., Zhang X. (2023). Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity. Stem Cell. Res. Ther. 14, 11. 10.1186/s13287-022-03233-z - DOI - PMC - PubMed
    1. Chichagova V., Hallam D., Collin J., Zerti D., Dorgau B., Felemban M., et al. (2018). Cellular regeneration strategies for macular degeneration: past, present and future. Eye (Lond). 32 (5), 946–971. 10.1038/s41433-018-0061-z - DOI - PMC - PubMed
    1. Deuse T., Hu X., Gravina A., Wang D., Tediashvili G. (2019). Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat. Biotechnol. 37, 252–258. 10.1038/s41587-019-0016-3 - DOI - PMC - PubMed

Publication types

LinkOut - more resources